Overview Fundamentals API Earnings EOD API Sample Code Pricing

PTC Therapeutics Inc (PTCT NASDAQ) stock market data APIs

$42.49 -0.69(-1.6%) as of November 6, 2024
Price chart is built with Anychart

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders in the United States and internationally. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy; Upstaza to treat aromatic l-amino acid decarboxylas (AADC) deficiency, a central nervous system disorder; Tegsedi and Waylivra for the treatment of rare diseases; and Evrysdi to treat spinal muscular atrophy (SMA) in adults and children. Its development pipeline products include Sepiapterin for the treatment of phenylketonuria; PTC518 splicing platform, which is being developed for the treatment of Huntington's disease; and ferroptosis and inflammation platforms, including vatiquinone to treat Friedreich ataxia and utreloxastat for the treatment of amyotrophic lateral sclerosis. The company distributes its products through third-party distributors. It has collaborations with F. Hoffman-La Roche Ltd, Hoffman-La Roche Inc., the SMA Foundation, National Taiwan University, Akcea Therapeutics, Inc., and Shiratori Pharmaceutical Co., Ltd. PTC Therapeutics, Inc. was incorporated in 1998 and is headquartered in South Plainfield, New Jersey.

PTC Therapeutics Inc Financial Data Overview

43.18
42.49
-
43.27
41.7
18.15-43.4
3 322 M
76 924 K
900 M
0.649
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'PTCT',
Type: 'Common Stock',
Name: 'PTC Therapeutics Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000QT15P7',
ISIN: NULL,
CUSIP: NULL,
CIK: '1070081',
EmployerIdNumber: '04-3416587',
FiscalYearEnd: 'December',
IPODate: '2013-06-20',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

PTC Therapeutics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 900 M
  • EBITDA 12 719 K
  • Earnings Per Share -6.67
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get PTC Therapeutics Inc Earnings via APIs

  • Latest Release 2024-11-07
  • EPS/Forecast -1.44

Get PTC Therapeutics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com